Prostate Cancer Coverage from Every Angle

Anthony V. D’Amico, MD, PhD, on Adjuvant vs Early Salvage Radiation Therapy After Prostatectomy

Posted: Thursday, September 1, 2022

Anthony V. D’Amico, MD, PhD, of Brigham and Women’s Hospital and Dana-Farber Cancer Institute, discusses data comparing adjuvant and early salvage radiation therapy for patients with prostate cancer who are at high risk for recurrence following radical prostatectomy and risk of death. The findings suggest that adjuvant radiation therapy be considered in those with pN1 or Gleason score 8 to 10 and pT3/4 disease, given the possibility that a significant reduction in all-cause mortality risk exists.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.